BiomX

HLSQNYSE United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.859 M

$0.68 -5.42%

Close of 17 Sept 2026

Revenue

—

Not reported

Earnings

-$36.2M

Loss-making

Shares outstanding

10,146,516

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

BiomX lists more than one class of stock. Company figures above cover all classes combined.

PHGE

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 159 →

#155Calidi BiotherapeuticsCLDI$3.28M
#156CurisCRIS$2.28M
#157Silexion TherapeuticsSLXN$2.19M
#158BiomXHLSQ$1.86M
#159Scinai ImmunotherapeuticsSCNI$812.2K

What if BiomX were worth as much as…

Open the what-if tool →

Gold $30.3T

$11,096,860

Per share 16,294,948× higher

Bitcoin $1.54T

$563,337.27

Per share 827,221× higher

Nvidia $5.29T

$1,936,298

Per share 2,843,316× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for BiomX are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 18 Sept 2026. Read the methodology.